Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions

Area of Science:

• Infectious Diseases
• Orthopedics
• Microbiology

Background:

• Osteomyelitis is a serious inflammatory bone disease leading to progressive destruction.
• Staphylococci, particularly *Staphylococcus aureus* and *Staphylococcus epidermidis*, are the primary causative agents.
• Increasing antibiotic resistance in staphylococci complicates treatment and contributes to recurrent infections.

Purpose of the Study:

• To provide a comprehensive overview of staphylococcus-induced osteomyelitis.
• To detail the clinical presentation, diagnosis, and pathophysiology of the disease.
• To discuss complications and explore future therapeutic strategies for osteomyelitis.

Main Methods:

• This is a review article.
• Information was gathered from existing literature on osteomyelitis.
• The review synthesizes data on clinical aspects, microbial causes, and treatment challenges.

Main Results:

• Staphylococcal infections are a major cause of osteomyelitis, characterized by bone destruction.
• Recurrent and persistent infections affect approximately 40% of patients, highlighting treatment difficulties.
• Antibiotic resistance and the need for surgical intervention complicate patient outcomes.

Conclusions:

• Osteomyelitis caused by staphylococci remains a significant clinical challenge.
• Effective management requires understanding the disease's complex pathophysiology and microbial resistance.
• Future research into novel treatment avenues is crucial for improving patient outcomes.